AirAnswers® is the only company providing airborne allergen detection either through physicians, industrial hygienists, indoor air quality professionals, home resale or direct to consumer. It has developed highly sensitive patented technology for testing and measuring biological agents in the air, including viruses and specifically SARS-CoV-2.
AirAnswers' vision is to improve health and happiness by finding allergy and mold solutions in transforming the home environment critical to our wellbeing. Our mission is to deliver the most personalized prevention and management solutions for allergies, asthma, and respiratory conditions.
Dr. James Koziarz
Dr. Koziarz was President and CEO of Rubicon Genomics, a leader in the commercialization of preanalytical processes to improve the performance and capabilities of analytical platforms for research and clinical testing. The company was sold to Takara Bio in 2017. Previously he worked for 25 years in the Diagnostics Division of Abbott Laboratories, including 11 years as a corporate officer where he managed groups involved in product development, manufacturing and customer technical support, and new technology management. Since retirement from Abbott, he has been an active member of the entrepreneurial and venture communities, serving as an advisor to PhysIQ and several early stage, venture-backed life sciences companies. Prior to joining Abbott in 1979, Jim was a postdoctoral fellow in biochemistry at the University of Chicago. He earned a B.S. in chemistry from DePaul University, a Ph.D. in biochemistry from the University of Chicago, and won a National Research Service Award as a postdoctoral fellow.
Julian is a world renowned serial inventor who has made groundbreaking contributions to multiple fields of science. His group at Abbott Labs was responsible for developing lateral flow immunoassay technology, which led to the first home pregnancy tests. Prior to Abbott Labs, Julian's group at Novartis (then CIBA-GEIGY) was responsible for inventing the Western Blot, an important method used today in molecular biology, biochemistry and immunogenetics for the characterization and detection of proteins. As a scientist, Julian is passionate about using evidence-based data to prevent human suffering. As he explains, "I know of no greater suffering than a mother in anguish about her child not being able to breathe normally – and not knowing what to do about it. I feel so fortunate to be part of an incredible team working to solve this problem".
Rachel oversees our lab, where we analyze air that has been sampled from our clients' homes. She has 10+ years of laboratory and management experience from top institutions, including the University of Chicago and Cincinnati Children's Hospital Medical Center. Rachel's professional passion is ensuring that we are using the best systems and processes in order to provide our clients with accurate and actionable data. "What excites me the most about my work is seeing the difference our data makes in our clients' lives," she explains. Rachel lives in Chicago with her fiancé and two cats, Ernie and Spanky, who suffer from feline allergies.
Katie brings her unique early-stage healthcare start-up experience to Customer Care and Marketing at Inspirotec. Her passion for building the best service experience for each customer has helped her launch training, quality, and customer care departments in her career. She believes that AirAnswers® has the power to improve the lives of allergy and asthma sufferers like herself and is excited to help customers experience the "we do better" Inspirotec mindset firsthand.
Steve has over three decades of healthcare industry experience and a Ph.D. in Biochemistry from Northwestern University. Prior to joining Inspirotec, Steve was Associate VP for Innovation and Industry Relations at Rosalind Franklin University of Medicine and Science. He serves as an advisor and member on various healthcare non-profit and start-up company boards, and is Past-Chair of the Life Sciences Executive Committee for the Licensing Executive Society.